?. Qui-sensibilise, 61 3.6. Sujets sur lesquels les patients veulent être sensibilisés, p.65

G. Le, Annexe 1 : Graphique d'évolution du pourcentage de vaccination d'après, p.92

. Buisson-nicand and . Saliou, La Grippe en face. Xavier Montauban, 2007.

G. Lagathu and R. Colimon, Grippe: vaccination, prophylaxie et traitement par les antiviraux

P. Hannoun-léophonte, La grippe conception actuelles, 2003.

G. Ppt, Available from: http://www.infectiologie.com/site/medias/alertes/grippe/GRIPPE-H1N1- diaporamaNANCY, 2014.

A. Lowen, S. Mubareka, J. Steel, and P. Palese, Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature, PLoS Pathogens, vol.101, issue.10, p.151, 2007.
DOI : 10.1371/journal.ppat.0030151.st001

URL : https://doi.org/10.1371/journal.ppat.0030151

. La-grippe-saisonnière-em|consulte, Available from

A. Grossesse-et-grippe-pandã©mique, Actualités pour les anesthésistes réanimateurs -1-s2.0-S075076581000002X-main.pdf [Internet], pp.59-2030, 2009.

P. Charboneau and M. , Infectiologie en réanimation, pp.187-195
DOI : 10.1007/978-2-8178-0389-0

N. Influenza and A. Disease, Information for Health Professionals [Internet], 2014.

V. Grippal-agent-de-la-grippe, Available from: http://www.inrs.fr/eficatt/eficatt.nsf/(allDocParRef)/FCGRIPPE?OpenDocument 28. WHO--Work programme. Manuel de sécurité biologique en laboratoire. Genève: Organisation mondiale de la santé, 2005.

L. Symptômes, ?. Le, and . Acces, Available from, 2014.

L. Vaccins-contre, Available from: http://www.infectiologie.com/site/medias/enseignement/du-lyon/2014-DUCIV-Lyon- Escuret_vaccin_grippe.pdf 36, 2014.

D. Bandt, S. Monecke, C. Scott, A. Gall, B. Hoffmann et al., Economic high-throughput-identification of influenza A subtypes from clinical specimens with a DNA-oligonucleotide microarray in an outbreak situation, Molecular and Cellular Probes, vol.26, issue.1, pp.6-10, 2012.
DOI : 10.1016/j.mcp.2011.10.003

V. Ryabinin, E. Kostina, G. Maksakova, A. Neverov, K. Chumakov et al., Universal Oligonucleotide Microarray for Sub-Typing of Influenza A Virus, PLoS ONE, vol.22, issue.4, p.17529, 2011.
DOI : 10.1371/journal.pone.0017529.s005

J. Stanicova, P. Mi?kovsk?, and V. ?utiak, Amantadine: an antiviral and antiparkinsonian agent, 2001.

A. Winquist, K. Fukuda, C. Bridges, and N. Cox, Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Morb Mortal Wkly Rep [Internet], 1999.

. Available, Inhibiteurs des neuraminidases ? au centre: oseltamivir -2010-03-110 Available from: http://www.medicalforum.ch/docs/smf Available from: http://www.isirv.org/site/index.php/resistance/methodology 49 Available from, -03-110.pdf 48. Methodology [Internet]..pdf 50. CDC H1N1 Flu | Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season [Internet], 2010.

C. Flu, Updated Interim Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications in the Treatment and Prevention of Influenza for the, Season [Internet], 2009.

J. Nguyen, J. Hoopes, M. Le, D. Smee, A. Patick et al., Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro, PLoS ONE, vol.348, issue.2, p.9332, 2010.
DOI : 10.1371/journal.pone.0009332.s006

J. Lu, Z. Guo, X. Pan, G. Wang, D. Zhang et al., Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice, Respiratory Research, vol.450, issue.6, p.43, 2006.
DOI : 10.1016/S0021-9673(00)90724-6

. Mesvaccins, net -fiche vaccin FLUENZ [Internet] Available from: https

M. Osterholm, N. Kelley, A. Sommer, and E. Belongia, Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.12, issue.1, pp.36-44, 2012.
DOI : 10.1016/S1473-3099(11)70295-X

. Pourquoi-se-faire-vacciner, Available from, 2014.

. Vaccination-contre-la-grippe, Questions / Réponses -Professionnels de santé -Ministère des Affaires sociales et de la Santé -www.sante.gouv.fr [Internet]. [cited Available from: http://www.sante.gouv.fr/vaccination-contre-la-grippe- saison-2013-2014-questions-reponses-professionnels-de-sante.html 72. les aspects economiques de la grippe -maladies et vaccinations [Lecture seule] -lesaspects-economiques-de-la-grippe-maladies-et-vaccinations, 2013.

M. Tang, J. Harp, and R. Wesley, Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK Arch Virol, pp.2125-2166, 2002.

. Grippe, Available from: http://www.inserm.fr/thematiques/microbiologie-et-maladies-infectieuses/dossiers-d- information/grippe 76. chidiac-grippe-jni03

. Grippe, Available from: http://www.invs.sante.fr/Dossiers- thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale, Dossiers thématiques / Accueil [Internet], 2014.

C. Internet and ]. , Available from, 2014.

1. O. Robert-o and . Pdf, Available from: http://streams.univ- lyon1.fr/videoStream/streams/lyon125 rencontres/O.ROBERT.pdf 85 Visualisation LettreBiblioCERC [Internet] Available from, 2014.

1. E. Bouvet, Available from: http://streams.univ- lyon1.fr/videoStream/streams/lyon1, BOUVET.pdf [Internet], vol.95728, 2014.

~. Inull-itô-do, lnotion (Q;l,d.I.,.cc